USE OF FAVIPIRAVIR IN THE MANAGEMENT OF COVID-19 2020-08-26T18:32:11+02:00Jul 22nd, 2020|MAC Advisories| Advisory on Favipiravir-22 July 2020 Rapid Review of Favipiravir for COVID-19_25June2020 facebooktwitterlinkedinwhatsappEmail Related Posts RESPONSE TO THE IDENTIFICATION OF A NEW VARIANT (OMICRON) Background document supporting the recommendations for selective vaccination of children 12-17 years old with COVID-19 vaccines in South Africa. BACKGROUND DOCUMENT MANDATORY COVID-19 VACCINATIONS IN CERTAIN WORKPLACES MAC Advisory: MITIGATING THE IMPACT OF COVID-19 DURING THE MUNICIPAL ELECTIONS – UPDATE
